Allurion Technologies Inc. logo

Allurion Technologies Inc. (ALUR)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
1. 68
+0.02
+1.2%
$
12.51M Market Cap
- P/E Ratio
0% Div Yield
24,865 Volume
- Eps
$ 1.66
Previous Close
Day Range
1.64 1.69
Year Range
1.02 16.81
Want to track ALUR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALUR closed yesterday higher at $1.68, an increase of 1.2% from Thursday's close, completing a monthly increase of 8.39% or $0.13. Over the past 12 months, ALUR stock lost -86.56%.
ALUR is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 1.27%. On average, the company has surpassed earnings expectations by 0.64%, based on the last three reports.
Allurion Technologies Inc. has completed 2 stock splits, with the recent split occurring on Jan 03, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ALUR Chart

Similar

Nuvation Bio Inc.
$ 0.3
+10.14%
Vicarious Surgical Inc.
$ 2.57
-5.17%
CCM
Concord Medical Services Holdings Ltd. - Sponsored ADR
$ 4.29
-3.92%
4 Medical Product Stocks to Watch From a Challenging Industry

4 Medical Product Stocks to Watch From a Challenging Industry

The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.

Zacks | 3 weeks ago
Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript

Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript

Allurion Technologies Inc. ( ALUR ) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Tara Brady Shantanu Gaur - Co-Founder, CEO, President, Principal Financial & Accounting Officer and Director Conference Call Participants Joshua Jennings - TD Cowen, Research Division Presentation Operator Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.

Seekingalpha | 1 month ago
Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates

Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates

Allurion Technologies, Inc. (ALUR) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to earnings of $0.25 per share a year ago.

Zacks | 3 months ago

Allurion Technologies Inc. (ALUR) FAQ

What is the stock price today?

The current price is $1.68.

On which exchange is it traded?

Allurion Technologies Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ALUR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 12.51M.

Has Allurion Technologies Inc. ever had a stock split?

Allurion Technologies Inc. had 2 splits and the recent split was on Jan 03, 2025.

Allurion Technologies Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Shantanu K. Gaur CEO
NYSE Exchange
02008G102 CUSIP
US Country
134 Employees
- Last Dividend
3 Jan 2025 Last Split
- IPO Date

Overview

Allurion Technologies Inc. is a healthcare company dedicated to combating obesity through an innovative weight loss platform aimed at treating individuals who are overweight. With its headquarters in Natick, Massachusetts, Allurion Technologies pioneers in offering an alternative solution to traditional, invasive weight loss procedures. This approach is centered around a holistic program that integrates a unique product—the Allurion Balloon—with a comprehensive suite of digital and telehealth services designed to support patients' weight loss journeys effectively and sustainably.

Products and Services

  • The Allurion Balloon

A centerpiece of the Allurion Program, this swallowable and procedure-less intragastric balloon is designed to facilitate weight loss. Unlike surgical alternatives, the Allurion Balloon is a non-invasive device that temporarily resides in the stomach, creating a feeling of fullness, which helps reduce food intake. This innovative approach allows for weight loss without the need for surgery, offering a less intimidating solution for those seeking to lose weight.

  • Allurion Virtual Care Suite

Alongside the Allurion Balloon, Allurion Technologies introduces a comprehensive digital health ecosystem to support patients throughout their weight loss journey. This suite includes AI-powered remote patient monitoring tools that allow for personalized and adaptive weight loss plans, a proprietary behavior change program designed to help individuals adopt healthier lifestyle practices, secure messaging for direct communication with healthcare providers, and video telehealth services for convenient access to professional guidance and support. This integrated, patient-centered platform leverages modern technology to enhance the efficacy of the Allurion Program, paving the way for a more engaged, informed, and successful weight management experience.

Contact Information

Address: 11 Huron Drive
Phone: 508 647 4000